XML 29 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,608,702) $ (1,658,641)
Adjustments to reconcile net loss to net cash used in operating activities:    
 Loss on disposal of fixed assets 3,712
Depreciation and amortization 454,876 84,358
Allowance for bad debts 47,262
Stock-based compensation 2,527,650 139,557
Stock issued in exchange for professional services 2,907,000 297,500
 Paycheck protection program loan forgiveness (108,532)
Changes in assets and liabilities:    
Accounts receivable (383,059) 65,833
Inventories (206,031) (241,876)
Prepaid expenses and other assets (220,339) (47,058)
Accounts payable 587,482 84,291
Accrued expenses and other liabilities (1,649,198) 60,765
Contract liabilities 141,644 504,592
Net cash used in operating activities (3,506,235) (710,679)
CASH FLOW FROM INVESTING ACTIVITIES:    
Purchases of fixed assets (210,576) (6,173)
Acquisition of MicaSense (14,536,863)
Acquisition of Measure (9,445,258)
Platform development costs (369,060)
Net cash used in investing activities (24,561,757) (6,173)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from promissory note 107,439
Issuance of Series E Preferred stock 1,010,000
Repurchase of Series E Preferred stock (1,110,880)
Sales of Common stock, net of issuance cost 34,961,104 12,896,742
Sale of Common stock from exercise of warrants 8,305,368 3,267
Exercise of stock options 75,825
Net cash provided by financing activities 43,342,297 12,906,568
Net increase in cash 15,274,305 12,189,716
Cash at the beginning of the year 23,940,333 717,997
Cash at the end of the period 39,214,638 12,907,713
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest cash paid
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of Series B, C, D and E preferred stock into Common stock 6,441
Deemed dividends 7,884,207
Liability related to MicaSense Acquisition 5,000,000
Stock consideration for MicaSense Acquisition 3,000,000
Liability related to Measure Acquisition 5,471,592
Stock consideration for Measure Acquisition $ 24,375,000